57,365 Shares in Avidity Biosciences, Inc. (NASDAQ:RNA) Purchased by Profund Advisors LLC

Profund Advisors LLC acquired a new position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 57,365 shares of the biotechnology company’s stock, valued at approximately $881,000. Other hedge funds and other institutional investors have also […]

Related Keywords

,Nasdaq ,Wells Fargo Company ,Ameritas Investment Partners Inc ,Daiwa Securities Group Inc ,Profund Advisors ,Exchange Commission ,Needham Company ,Avidity Biosciences Inc ,Avidity Biosciences Company Profile ,Credit Suisse Group ,Belpointe Asset Management ,Avidity Biosciences ,Free Report ,Asset Management ,Investment Partners ,Securities Group ,Get Free Report ,Suisse Group ,Visit Holdingschannel ,Avidity Biosciences Daily ,Nasdaq Rna ,Rna ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,